Zobrazeno 1 - 10
of 49
pro vyhledávání: '"N M S de Groot"'
Autor:
M J Tilly, Z Lu, S Geurts, B H Stricker, J A Labrecque, M K Ikram, M P M De Maat, N M S De Groot, M Kavousi
Publikováno v:
European Journal of Preventive Cardiology. 30
Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Senior Scientist Grant from the Dutch Heart Foundation. Aims Due to their dependence on temporality, current atrial fibrillation (AF) classifications are inaccurate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5ce19572e43446dbb746a13020dbc38
https://doi.org/10.1093/eurjpc/zwad125.203
https://doi.org/10.1093/eurjpc/zwad125.203
Autor:
M S Van Schie, N L Ramdat Misier, P Knops, A Heida, R K Kharbanda, Y J H J Taverne, N M S De Groot
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Atrial extrasystoles (AES) originating from the pulmonary veins are notorious for triggering episodes of atrial fibrillation (AF). However, non-pulmonary vein triggers, emerging from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f6f6ab1de2a0953b575eb47bdf910b9
https://doi.org/10.1093/europace/euad122.004
https://doi.org/10.1093/europace/euad122.004
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Atrial extrasystoles (AES) are notorious for triggering episodes of atrial fibrillation (AF). AES provoke conduction disorders due to (dispersion in) refractoriness and enhanced non-u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9955db8f8ad1962bb6033fcfb1ec6f7
https://doi.org/10.1093/europace/euad122.588
https://doi.org/10.1093/europace/euad122.588
Publikováno v:
European Journal of Preventive Cardiology. 30
Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Senior Scientist Grant from the Dutch Heart Foundation. Background and Aims The underlying mechanisms of atrial fibrillation (AF) are largely unknown. Inflammation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::332b7d229ff690dca14e15a2f83a3998
https://doi.org/10.1093/eurjpc/zwad125.201
https://doi.org/10.1093/eurjpc/zwad125.201
Publikováno v:
European Heart Journal. 43
Background Atrial fibrillation (AF) is the most common cardiac arrythmia worldwide, with an increased risk of comorbidity, and significant sex differences in pathophysiology and prognosis. Cardiometabolic disorders, including obesity, hypertension, d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcb7932a7dabeb7b82a1096153e6ff4e
https://doi.org/10.1093/eurheartj/ehac544.2241
https://doi.org/10.1093/eurheartj/ehac544.2241
Publikováno v:
European Heart Journal. 43
Background Bachmann's Bundle (BB) is the main preferential route for interatrial conduction and plays an important role in initiation and perpetuation of atrial tachyarrhythmia such as atrial fibrillation (AF). Especially in patients with inter- and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9fa6d0e062439c1bc5aacbff453de79
https://doi.org/10.1093/eurheartj/ehac544.483
https://doi.org/10.1093/eurheartj/ehac544.483
Publikováno v:
European Heart Journal. 43
Background Atrial fibrillation (AF) is a major health burden worldwide, with significant sex differences in epidemiology and risk factors. Amyloid-β40 (Aβ40) and Amyloid-β42 (Aβ42), the hallmark of cerebral amyloid angiopathy, have recently been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a02e5da6021be7fe55bf2498e1c6e8e
https://doi.org/10.1093/eurheartj/ehac544.2302
https://doi.org/10.1093/eurheartj/ehac544.2302
Autor:
N Ramdat Misier, Y J H J Taverne, M S Van Schie, R K Kharbanda, P C Van De Woestijne, W J Van Leeuwen, B Bartels, A J J C Bogers, N M S De Groot
Publikováno v:
European Heart Journal. 43
Background Despite improvement in (timing of) of intervention or surgery, atrial fibrillation (AF) still occurs more often and at a younger age in patients with congenital heart disease (CHD) than in the general population. This suggests that in this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5921056a2976ca641781f156eb6c4222
https://doi.org/10.1093/eurheartj/ehac544.1524
https://doi.org/10.1093/eurheartj/ehac544.1524
Autor:
J Griffiths, J Liang, P Khairy, U N Srivatsa, D Frankel, A Sandhu, M B Shoemaker, A Natale, D Lakkireddy, N M S De Groot, E Gerstenfeld, J P Moore, P Avila, S Ernst, D T Nguyen
Publikováno v:
European Heart Journal. 43
Background Life expectancies for patients with congenital heart disease (CHD) have dramatically increased in recent years, accompanied by a rise in atrial fibrillation (AF) prevalence. Data on AF ablation strategy and outcomes are limited in CHD. Pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2e36af01b16fb2f6c1030c86adbae27
https://doi.org/10.1093/eurheartj/ehac544.1851
https://doi.org/10.1093/eurheartj/ehac544.1851
Autor:
N. M. S. de Groot, M.J Tilly, M. A. Ikram, S Geurts, M.P.M. de Maat, Z Lu, Mohammad Kamran Ikram, Maryam Kavousi
Publikováno v:
European Heart Journal. 42
Background In a clinical setting, atrial fibrillation (AF) subgroups are defined, including paroxysmal, persistent, and permanent AF. These subgroups differ in terms of clinical characteristics, management strategy, and long-term outcomes. Applicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7ccf30ee6da4084e480517a7b5a7377
https://doi.org/10.1093/eurheartj/ehab724.2415
https://doi.org/10.1093/eurheartj/ehab724.2415